Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins
US6245737A · kind A · utility
11Cited by
6References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 19, 1998 |
| Grant date | Jun 12, 2001 |
| Priority date | — |
| Expiry date | Aug 19, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides antiviral proteins, peptides and conjugates, as well as methods of obtaining these agents. The antiviral proteins, peptides and conjugates of the present invention can be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.